# | Title | Journal | Year | Citations |
---|
1 | Clinical use of anti-TNF therapy and increased risk of infections | Drug, Healthcare and Patient Safety | 2013 | 185 |
2 | Antidepressant-associated sexual dysfunction: impact, effects, and treatment | Drug, Healthcare and Patient Safety | 2010 | 157 |
3 | Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies | Drug, Healthcare and Patient Safety | 2015 | 143 |
4 | Point prevalence of hospital-acquired infections in two teaching hospitals of Amhara region in Ethiopia | Drug, Healthcare and Patient Safety | 2016 | 78 |
5 | Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam | Drug, Healthcare and Patient Safety | 2014 | 75 |
6 | Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children | Drug, Healthcare and Patient Safety | 2014 | 66 |
7 | An exploratory study on medications in Qatar homes | Drug, Healthcare and Patient Safety | 2011 | 61 |
8 | Update on the renal toxicity of iodinated contrast drugs used in clinical medicine | Drug, Healthcare and Patient Safety | 2017 | 61 |
9 | Adverse drug reactions in older patients: an Italian observational prospective hospital study | Drug, Healthcare and Patient Safety | 2012 | 57 |
10 | Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors | Drug, Healthcare and Patient Safety | 2009 | 54 |
11 | Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study | Drug, Healthcare and Patient Safety | 2011 | 51 |
12 | Extent of dispensing prescription-only medications without a prescription in community drug retail outlets in Addis Ababa, Ethiopia: a simulated-patient study | Drug, Healthcare and Patient Safety | 2016 | 47 |
13 | Clinical use of antidepressant therapy and associated cardiovascular risk | Drug, Healthcare and Patient Safety | 2012 | 45 |
14 | Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management | Drug, Healthcare and Patient Safety | 2010 | 42 |
15 | Therapeutic potential of medicinal marijuana: an educational primer for health care professionals | Drug, Healthcare and Patient Safety | 2018 | 40 |
16 | Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder | Drug, Healthcare and Patient Safety | 2009 | 39 |
17 | Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs | Drug, Healthcare and Patient Safety | 2010 | 38 |
18 | Prevalence and factors associated with off-label antidepressant prescriptions for insomnia | Drug, Healthcare and Patient Safety | 2011 | 38 |
19 | Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study | Drug, Healthcare and Patient Safety | 2014 | 38 |
20 | Evaluation of medication package inserts in Saudi Arabia | Drug, Healthcare and Patient Safety | 2012 | 37 |
21 | Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir | Drug, Healthcare and Patient Safety | 2014 | 37 |
22 | Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives | Drug, Healthcare and Patient Safety | 2009 | 36 |
23 | Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening | Drug, Healthcare and Patient Safety | 2012 | 36 |
24 | Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia | Drug, Healthcare and Patient Safety | 2015 | 34 |
25 | Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence | Drug, Healthcare and Patient Safety | 2011 | 33 |
26 | New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy | Drug, Healthcare and Patient Safety | 2014 | 32 |
27 | Antiepileptic drugs and suicidality | Drug, Healthcare and Patient Safety | 2010 | 31 |
28 | Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis | Drug, Healthcare and Patient Safety | 2011 | 31 |
29 | <p>Patient Safety Culture and Associated Factors Among Health Care Providers in Bale Zone Hospitals, Southeast Ethiopia: An Institutional Based Cross-Sectional Study</p> | Drug, Healthcare and Patient Safety | 2020 | 31 |
30 | Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study | Drug, Healthcare and Patient Safety | 2014 | 30 |
31 | Update on the usage and safety of epinephrine auto-injectors, 2017 | Drug, Healthcare and Patient Safety | 2017 | 30 |
32 | Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania | Drug, Healthcare and Patient Safety | 2013 | 28 |
33 | Safety and tolerability of antipsychotics: focus on amisulpride | Drug, Healthcare and Patient Safety | 2010 | 27 |
34 | Patient considerations in the use of tapentadol for moderate to severe pain | Drug, Healthcare and Patient Safety | 2013 | 27 |
35 | Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran | Drug, Healthcare and Patient Safety | 2014 | 27 |
36 | Positive clinical outcomes derived from using <em>Streptococcus salivarius</em> K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation | Drug, Healthcare and Patient Safety | 2016 | 27 |
37 | The economic burden of patient safety targets in acute care: a systematic review | Drug, Healthcare and Patient Safety | 2012 | 26 |
38 | Update on the safety and bioequivalence of biosimilars – focus on enoxaparin | Drug, Healthcare and Patient Safety | 2013 | 26 |
39 | Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature | Drug, Healthcare and Patient Safety | 2013 | 26 |
40 | Knowledge of drug prescription in dentistry students | Drug, Healthcare and Patient Safety | 2012 | 25 |
41 | Awareness among nurses about reporting of adverse drug reactions in Sweden | Drug, Healthcare and Patient Safety | 2012 | 25 |
42 | Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study | Drug, Healthcare and Patient Safety | 2013 | 25 |
43 | Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder | Drug, Healthcare and Patient Safety | 2014 | 25 |
44 | <p>Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis</p> | Drug, Healthcare and Patient Safety | 2020 | 25 |
45 | Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis | Drug, Healthcare and Patient Safety | 2015 | 24 |
46 | Knowledge among drug dispensers and antimalarial drug prescribing practices in public health facilities in Dar es Salaam | Drug, Healthcare and Patient Safety | 2013 | 23 |
47 | Topical steroid addiction in atopic dermatitis | Drug, Healthcare and Patient Safety | 0 | 23 |
48 | <p>Rational Drug-Use Evaluation Based on World Health Organization Core Drug-Use Indicators in a Tertiary Referral Hospital, Northeast Ethiopia: A Cross-Sectional Study</p> | Drug, Healthcare and Patient Safety | 2020 | 23 |
49 | Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy | Drug, Healthcare and Patient Safety | 2010 | 22 |
50 | <p>Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study</p> | Drug, Healthcare and Patient Safety | 2020 | 22 |